Evidence map›Paper›PMID 39130813›Full record

ArticleClinical case reports2024

New-onset sarcoidosis in a patient with long COVID.

Guillermo Rodriguez-Nava, Vanessa El Kamari, Harvey Chang, Goar Egoryan, Hector F Bonilla

Abstract readCase Reports
In one paragraph

Article in Clinical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Guillermo Rodriguez-NavaDivision of Infectious Diseases and Geographic Medicine, Department of Medicine Stanford University School of Medicine Stanford California USA.ORCID https://orcid.org/0000-0001-9826-7050
Vanessa El KamariDivision of Infectious Diseases and Geographic Medicine, Department of Medicine Stanford University School of Medicine Stanford California USA.
Harvey ChangDepartment of Pathology Memorial Medical Center Modesto California USA.
Goar EgoryanDivision of Oncology, Department of Medicine Stanford University School of Medicine Stanford California USA.ORCID https://orcid.org/0000-0001-5203-8156
Hector F BonillaDivision of Infectious Diseases and Geographic Medicine, Department of Medicine Stanford University School of Medicine Stanford California USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long COVID, often following SARS-CoV-2 infection, may stem from sustained inflammation, overlapping with autoimmune diseases like sarcoidosis. Though specific treatments lack, this link could shape future diagnostic and therapeutic methods.

Indexed as

autoimmuneCOVID‐19long COVIDsarcoidosis

Identifiers

PMID39130813
PMCPMC11316136

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.